5-methylcytosine has been researched along with Myelodysplastic Syndromes in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ivanović, D; Krmek, DŽ; Ljubić, N; Magazin, M; Perković, L; Solomun, GF; Sučić, M | 1 |
| Chandra, D; Deka, R; Manivannan, P; Mishra, P; Pati, HP; Saxena, R; Singh, J; Tyagi, S | 1 |
| Liu, S; Liu, X; Luo, Y; Pei, M; Shen, J; Xiao, L; Xu, Y; Yi, Y; Zhang, G; Zheng, W; Zhong, H | 1 |
| Alesiani, F; Alfonsi, S; Berardinelli, E; Biagetti, S; Catarini, M; Centurioni, R; Costantini, B; Giantomassi, F; Goteri, G; Leoni, P; Mariani, M; Olivieri, A; Poloni, A; Serrani, F; Stramazzotti, D; Trappolini, S; Zizzi, A | 1 |
| Calvo, X; Costa, D; Esteve, J; Monzó, M; Muñoz, C; Navarro, A; Nomdedeu, B; Nomdedeu, M; Peña, O; Pereira, A; Risueño, RM; Tejero, R | 1 |
| Abdelhay, E; Batalha, AB; Boulhosa, AM; Bueno, AP; Coutinho, DF; Fernandez, TS; Gutiyama, LM; Monte-Mór, BC; Pombo-de-Oliveira, MS; Rouxinol, ST; Vianna, DT; Zalcberg, IR | 1 |
| Kriaucionis, S; McClellan, M; Schuster-Boeckler, B; Tomkova, M | 1 |
| Abboud, CN; Baty, JD; Cashen, AF; DiPersio, JF; Duncavage, EJ; Fehniger, TA; Fronick, CC; Fulton, RS; Ghobadi, A; Graubert, TA; Hantel, A; Heath, SE; Jacoby, MA; Janke, MR; Khan, N; Knoebel, RW; Lee, YS; Ley, TJ; Link, DC; Luber, K; Miller, CA; O'Laughlin, M; Oh, ST; Petti, AA; Pusic, I; Romee, R; Schroeder, MA; Stock, W; Stockerl-Goldstein, KE; Sukhanova, MJ; Tandon, B; Tomasson, MH; Uy, GL; Vij, R; Walter, MJ; Wartman, LD; Welch, JS; Westervelt, P; Wilson, RK | 1 |
| Agarwal, S; An, J; Aravind, L; Bandukwala, HS; Ganetzky, R; Huang, Y; Jankowska, AM; Ko, M; Koh, KP; Lamperti, ED; Liu, XS; Maciejewski, JP; Pape, UJ; Rao, A; Tahiliani, M | 1 |
1 trial(s) available for 5-methylcytosine and Myelodysplastic Syndromes
| Article | Year |
|---|---|
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Biomarkers, Tumor; Bone Marrow; Decitabine; Exome; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Myelodysplastic Syndromes; Prospective Studies; Risk Factors; Survival Rate; Tumor Suppressor Protein p53 | 2016 |
8 other study(ies) available for 5-methylcytosine and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Immunoexpression of 5-methylcytosine (5mc) in Bone Marrow Haematopoietic Cells in Patients with Myelodysplastic Syndromes.
Topics: 5-Methylcytosine; Aged; Aged, 80 and over; Anemia; Bone Marrow Cells; Case-Control Studies; Humans; Middle Aged; Myelodysplastic Syndromes | 2019 |
Utility of 5-Methylcytosine Immunohistochemical Staining to Assess Global DNA Methylation and Its Prognostic Impact in MDS Patients
Topics: 5-Methylcytosine; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Case-Control Studies; Disease Progression; DNA Methylation; Female; Follow-Up Studies; Genome, Human; Humans; Immunoenzyme Techniques; Male; Middle Aged; Myelodysplastic Syndromes; Prognosis; Prospective Studies; Retrospective Studies; Risk Factors; Staining and Labeling; Survival Rate; Young Adult | 2017 |
Decreased 5-hydroxymethylcytosine levels are associated with TET2 mutation and unfavorable overall survival in myelodysplastic syndromes.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Cytosine; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Female; Gene Expression Regulation; Humans; Male; Middle Aged; Mutation; Myelodysplastic Syndromes; Prognosis; Proto-Oncogene Proteins; Young Adult | 2013 |
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes.
Topics: 5-Methylcytosine; Aged; Aged, 80 and over; Bone Marrow; Bone Marrow Cells; Cell Lineage; Cytosine; DNA Methylation; Female; Humans; Long Interspersed Nucleotide Elements; Male; Middle Aged; Myelodysplastic Syndromes; Prognosis; Sequence Analysis, DNA | 2013 |
High levels of global DNA methylation are an independent adverse prognostic factor in a series of 90 patients with de novo myelodysplastic syndrome.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Bone Marrow; Cytosine; DNA; DNA Methylation; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Prognosis; Survival Analysis | 2014 |
TET2 expression level and 5-hydroxymethylcytosine are decreased in refractory cytopenia of childhood.
Topics: 5-Methylcytosine; Adolescent; Case-Control Studies; Child; Child, Preschool; Cytosine; Dioxygenases; DNA Mutational Analysis; DNA-Binding Proteins; Female; Gene Expression Regulation; High-Throughput Nucleotide Sequencing; Humans; Infant; Male; MicroRNAs; Mutation; Myelodysplastic Syndromes; Polymerase Chain Reaction; Proto-Oncogene Proteins; Transcriptome | 2015 |
5-hydroxymethylcytosine marks regions with reduced mutation frequency in human DNA.
Topics: 5-Methylcytosine; Brain Neoplasms; CpG Islands; Databases, Genetic; DNA Methylation; DNA, Neoplasm; Epigenesis, Genetic; Exome Sequencing; Humans; Kidney Neoplasms; Mutation Rate; Myelodysplastic Syndromes; Myeloid Cells | 2016 |
Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2.
Topics: 5-Methylcytosine; Animals; Biocatalysis; Cell Differentiation; Cell Line; CpG Islands; Dioxygenases; DNA Methylation; DNA-Binding Proteins; DNA, Neoplasm; Humans; Hydroxylation; Leukemia, Myeloid, Acute; Mice; Mice, Inbred C57BL; Mutant Proteins; Mutation; Myelodysplastic Syndromes; Proto-Oncogene Proteins | 2010 |